US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about DMT/Assisted Therapy
Recent news which mentions DMT/Assisted Therapy
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
VLS/01
Cannabis
DMT Clinical Trial
From
Benzinga
DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
April 03, 2024
Tickers
AGNPF
Tags
Cannabis
Management
AGNPF
From
Benzinga
Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
December 19, 2022
Tickers
DMTTF
Tags
News
DMT/Assisted Therapy
Benzinga
From
Benzinga
How Certain Psychedelics Produce Brain And Behavior Changes: UCL Leads New Study
December 16, 2022
Tickers
DMTTF
Tags
University College London
Offerings
Markets
From
Benzinga